BROKERS CHOICE: DIVISLAB, KOTAKBANK, SIEMENS, HAL, ADANIPOWER, MECROTECH, TITAN, ZYUDSLIFE, SUNPHARMA
AHMEDABAD, 8 JULY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.
HSBC on Divis Lab: Upgrade to Buy on Company, raise target price at Rs 7900 (Positive)
MS on Kotak Bank: Maintain Overweight on Bank, target price at Rs 2650 (Positive)
Jefferies on Kotak Bank: Maintain Buy on Bank, target price at Rs 2550 (Positive)
Jefferies on Siemens Energy: Initiate Buy on Company, target price at Rs 3500 (Positive)
JP Morgan on HAL: Maintain Overweight on Company, target price at Rs 6105 (Positive)
Jefferies on Adani Power: Initiate Buy on Company, target price at Rs 690 (Positive)
Nomura on Macrotech: Maintain Buy on Company, target price at Rs 1450 (Positive)
Macquarie on Sun Pharma: Maintain Outperform on Company, target price at Rs 2135 (Positive)
Jefferies on India Strategy: BSE and Nuvama to face the impact of SEBI banning Jane Street from Indian stock market (Neutral)
MS on Titan: Maintain Overweight on Company, target price at Rs 3876 (Neutral)
Citi on Titan: Maintain Neutral on Company, target price at Rs 3800 (Neutral)
CLSA on Titan: Maintain Outperform on Company, target price at Rs 4236 (Neutral)
Macquarie on Cipla: Maintain Outperform on Company, cut target price at Rs 1700 (Neutral)
Macquarie on Lupin: Maintain Outperform on Company, cut target price at Rs 2350 (Neutral)
Macquarie on Zydus Life: Maintain Outperform on Company, cut target price at Rs 1100 (Neutral)
Jefferies on Zydus Life: Maintain Buy on Company, target price at Rs 1150 (Neutral)
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
